Tumors were induced in adult and newborn rabbits by inoculation of fibroma virus. Whereas tumors completely regressed in adult rabbits by 3 weeks after virus inoculation, newborn rabbits supported tumor growth for 3 to 4 weeks. In the latter case, some animals died at this time, others survived with a gradual regression of the tumors over an additional period of 5 to 6 weeks. Virus neutralization studies demonstrated antibodies to fibroma virus in the serum from both adult and newborn tumor-bearing rabbits. Newborn rabbits with progressively growing tumors failed to elicit a delayed cutaneous hypersensitivity reaction to fibroma antigens, whereas adult rabbits showed strong reactions as early as 7 days after tumor induction. Similarly, macrophage migration inhibition tests revealed that the lymphocytes from newborn rabbits with progressively growing tumors were only weakly reactive to fibroma antigens, as compared to lymphocytes from adult tumorbearing rabbits. In contrast, newborn rabbits that survived and regressed the tumors demonstrated strong cell-mediated immunity both by skin testing and migration inhibition. Virus growth studies in cell culture demonstrated that fibroma was unable to replicate in peritoneal macrophages from either newborn or adult rabbits. No differences were observed in growth of the virus in macrophages from tumor-bearing rabbits. The significance of these observations is discussed in respect of the possible role of cell-mediated immunity in fibroma tumor regression.
Tumors were induced in adult and newborn rabbits by inoculation of fibroma virus. Whereas tumors completely regressed in adult rabbits by 3 weeks after virus inoculation, newborn rabbits supported tumor growth for 3 to 4 weeks. In the latter case, some animals died at this time, others survived with a gradual regression of the tumors over an additional period of 5 to 6 weeks. Virus neutralization studies demonstrated antibodies to fibroma virus in the serum from both adult and newborn tumor-bearing rabbits. Newborn rabbits with progressively growing tumors failed to elicit a delayed cutaneous hypersensitivity reaction to fibroma antigens, whereas adult rabbits showed strong reactions as early as 7 days after tumor induction. Similarly, macrophage migration inhibition tests revealed that the lymphocytes from newborn rabbits with progressively growing tumors were only weakly reactive to fibroma antigens, as compared to lymphocytes from adult tumorbearing rabbits. In contrast, newborn rabbits that survived and regressed the tumors demonstrated strong cell-mediated immunity both by skin testing and migration inhibition. Virus growth studies in cell culture demonstrated that fibroma was unable to replicate in peritoneal macrophages from either newborn or adult rabbits. No differences were observed in growth of the virus in macrophages from tumor-bearing rabbits. The significance of these observations is discussed in respect of the possible role of cell-mediated immunity in fibroma tumor regression.
Tumors induced in rabbits by Shope fibroma virus offer a system in which antibody and cellmediated immunity can be evaluated under conditions of progressive tumor growth and tumor regression without manipulation of the immune responses of the host. Intradermal inoculation of adult rabbits with fibroma virus results in tumors which grow for 9 to 11 days and then regress (1, 2, 6) . In contrast, tumors induced in newborn rabbits by fibroma virus grow progressively and frequently kill the animal (1) .
Cell-mediated immune response to fibroma tumors in the adult rabbits, as manifested by the delayed cutaneous hypersensitivity reaction, is detectable as early as 5 days after virus inoculation and remains positive after the tumor has regressed. In vitro macrophage migration inhibition showed a parallel lymphocyte sensitivity to virus-specific cell surface antigens (6) . Circulating antiviral antibody has been demonstrated by 7 days after virus inoculation of adult rabbits (1) . Similarly, antibody cytotoxic for fibromainfected cells appears by the end of the first week of tumor growth and increases in titer as the tumors regress (5, 7).
In the case of newborn tumor-bearing rabbits, antiviral (1) and cytotoxic antibodies (7) appear to develop normally, although the tumors continue to increase in size. However, unlike the adult tumor-bearing rabbits, these animals fail to demonstrate a delayed hypersensitivity reaction to the fibroma antigens (1) . Furthermore, passive transfer of lymph node lymphocytes from newborn tumor-bearing rabbits into the skin of adults bearing fibromas failed to elicit a delayed type reaction, whereas lymphocytes from adult tumor-bearing rabbits did (1) . This study was designed to investigate further the status of cell-mediated immunity to fibroma tumors in adult and newborn rabbits.
METHODS AND MATERIALS
Cell cultures. Cultures of primary rabbit kidiiey (PRK) cells were prepared as described (8) . PRK cells were grown in Eagle medium supplemented with 10% fetal calf serum (FCS), 100 U of penicillin/ml, 100 ug of streptomycin/ml, and 0.075% sodium bicarbonate. DRK3, a cloned line of rabbit kidney epithelial cells, was grown in medium 199 supplemented with 10%S FCS, antibiotics, and sodium bicarbonate.
TOMPKINS, SCHULTZ, AND RAMA RAO Virus and virus assay. The Patuxent strain of fibroma virus was grown in PRK cells. PRK monolayers in 0.473-liter prescription bottles were inoculated with 1.25 X 106 pock-forming units (PFU) of virus. After an adsorption period of 2 h at 25 C, 20 ml of Eagle medium was added and the cultures were incubated at35 C for60h. Virus was harvested by 3 cycles of freeze-thawing of the cultures followed by centrifugation at 800 rpm for 5 min to remove cell debris. Virus stocks were stored in 0.5-ml samples at -70 C. Uninfected monolayers of PRK cells were treated in the same manner as a source of control antigen. Fibroma virus was assayed by pock formation on DRK3 monolayers (8) .
Inoculation of rabbits with fibroma virus. Tumors were induced in adult New Zealand white rabbits (2-4 months of age) by intradermal inoculation at two sites on the shaved backs with 2.5 X 105 PFU of fibroma virus. Newborn rabbits (1-3 days of age) were inoculated subcutaneously with 2.5 X 106 PFU of fibroma virus. Serum was collected at weekly intervals after inoculation with virus from the ear vein of adult rabbits and by cardiac puncture from newborn rabbits. All sera were heat inactivated at 56 C for 1 h and stored in vials at -20 C.
Antibody neutralization of fibroma virus. The neutralization titer of serum was determined by reduction of pock formation on monolayers of DRK3 cells. Serial logio dilutions of the antiserum were mixed in equal volume with 104 PFU of fibroma virus and incubated for 1 h at 25 C. Undiluted and 1 to 10 dilutions of the reaction mixture (0.1 ml) were plated in duplicate on monolayers of DRK3 and incubated under an overlay of 1% methylcellulose to allow for pock formation. Virus alone and virus plus nonimmune serum were inoculated as controls. The neutralization titer of the serum was the highest dilution which reduced the pock-forming units by 50% or greater.
Skin testing. Adult and newborn tumor-bearing rabbits were tested for a delayed hypersensitivity reaction to fibroma antigens by intradermal inoculation of 0.1 ml of ultraviolet (UV)-inactivated or infectious fibroma virus (2.5 X 106 PFU/ ml) diluted in phosphate-buffered saline (6 Peritoneal exudate cells were collected from rabbits 72 h after intraperitoneal injection of sterile paraffin oil, as previously described (6) . Adult rabbits were injected with 40 ml of oil and newborn rabbits were injected with 2.5 to 10 ml, depending upon their age. Lymphocytes were obtained from the spleen, thymus, and draining lymph nodes, and were partially purified by passing through a glass bead column as described previously (9) . Migration inhibition test. The migration earlier publication (6 and 5% normal rabbit serum, and incubated at 37 C. The specific antigen consisted of UV-irradiated stock virus (2.5 X 107 PFU/ml) diluted 1:10 in Eagle medium, and control antigen consisted of an appropriate dilution of uninfected PRK cell lysate. Each system was tested with duplicate migration chambers containing two capillary tubes each. The area of migration was measured with an ocular micrometer after 24 h of incubation at 37 C, and inhibition was expressed as the difference in migration between cells incubated with fibroma antigen and those with uninfected cell lysates. The reactivity of lymphocytes to fibroma antigens was also measured by mixing lymphocytes from tumor-bearing rabbits with normal peritoneal exudate cells at a ratio of 1:4 and testing in the migration test as above.
Replication of fibroma virus in peritoneal macrophages. Peritoneal exudate cells were washed, counted, and 2 X 106 cells were incubated with 106 PFU of fibroma virus in a 1-ml volume for 90 min at 4 C with frequent shaking. After adsorption of virus the cells were washed twice with medium and suspended in medium at a concentration of 2.5 X 106 cells/ml. For growth curve experiments, 1-ml portions were placed in loosecapped tubes and incubated at 37 C in the presence of 5% CO2 in air. Duplicate samples were frozen at the beginning of the experiment and at the intervals to be tested. Virus was released from the cells by three cycles of freeze-thawing and pooled samples were assayed by pock formation on DRK3 monolayers (8) .
RESULTS
Tumor growth in adult and newborn rabbits. Inoculation of adult rabbits with fibroma virus resulted in tumors that grew for 9 to 12 days to reach a maximum size of 2.0 to 2.5 cm in diameter. This was followed by complete regression after 18 to 21 days as described previously (6). In contrast, tumors induced in newborn rabbits grew to a much greater size, ranging from 5 to 7 cm in diameter by 3 to 4 weeks after virus inoculation. These tumors showed no central necrosis and frequently remained solid and grossly unchanged for several weeks before undergoing a slow but gradual regression. Some tumorbearing rabbits died between 3 and 5 weeks after virus inoculation. Autopsies of these animals reveal multiple foci of fibrosarcomas in the liver, spleen, and kidneys. These cells were cultured and shown to have cytoplasmic fibroma virus antigens by the direct immunofluorescence test.
Since most of the tumor-bearing animals were sacrificed between 1 and 4 weeks after virus inoculation, we have no reliable information on the fraction of animals inoculated as newborns that would have survived and regressed the tumors.
Virus-neutralizing antibody in tumorbearing rabbits. Adult and newborn rabbits were tested for virus-neutralizing antibody at 2, 3, and 4 weeks after inoculation of virus. The adult rabbit showed an increase in serum antibody titer from 10-' to 10-2 between 2 and 4 weeks after virus inoculation (Table 1) . Similarly, newborn tumor-bearing rabbits demonstrated significant antibody titers against fibroma virus. The sera from three newborn rabbits tested after 2, 3, and 4 weeks of tumor growth caused a 50% reduction in virus titer when diluted 10-2, 10-3, and 103, respectively. The tumors increased in size during this time despite the increasing antibody titer. These results are in agreement with those of Allison (1) and with our previous demonstration of cytotoxic antibodies in newborn rabbits with progressively growing tumors (7) . Delayed hypersensitivity reaction in adult and newborn tumor-bearing rabbits. Skin tests performed on adult tumor-bearing rabbits by using UV-irradiated fibroma virus showed a positive reaction by the 5th day after tumor induction and remained positive through the period a Rabbits inoculated with fibroma virus as described in Table 1 .
b Percent inhibition = [1 -(mean area of migration with fibroma antigen)/(mean area of migration with uninfected PRK antigen)] X 100.
c Percent specific inhibition = (% inhibition of macrophages from tumor-bearing rabbits) -(% inhibition of macrophages from control rabbits).
d These numbers represent the mean and standard deviation of four different rabbits. The newborn control rabbits ranged from 2 to 5 weeks of age.
e NT, Not tested.
Macrophage migration inhibition using purified lymphocytes. Because of the difficulty in obtaining peritoneal exudate cells from young rabbits, lymphocyte immunity in newborn tumorbearing animals was further evaluated in a mixed migration inhibition test. Lymphocytes from the spleen, thymus, and lymph nodes of tumor-bearing rabbits were tested for sensitivity to fibroma antigens by mixing with macrophages from adult normal rabbits and testing for migration inhibition.
Normal rabbit macrophages were strongly inhibited from migrating in the presence of fibroma antigens when mixed with 20% lymph node lymphocytes from adult tumor-bearing rabbits (Table 3) . Lymphocytes from adult tumor-bearing rabbits caused 46.5%, 49.9%, and 37.6% specific inhibition of normal rabbit macrophages when tested at 14, 21, and 28 days after tumor induction, respectively. In contrast, lymph node lymphocytes from newborn tumor-bearing rabbits Peritoneal lymphocytes and lymph node lymphocytes showed a more marked immune reaction to fibroma antigens when tested after 35 days of tumor growth (Table 3) . These results parallel the previous experiment and show that newborn tumor-bearing rabbits have a depressed cell-mediated immune response, or reactivity to fibroma antigens during the productive phase of tumor development, or both. If the aniimals survive this phase, cell-mediated immunity, as measured by skin testing and migration inhibition, becomes more prominent and the tumors regress.
Replication of fibroma virus in peritoneal macrophages. Since macrophages are the predominant cell type invading the fibroma tumor, evidence was sought for a difference in susceptibility of macrophages from adult and newborn rabbits to fibroma virus replication. Inoculation of macrophages from normal adult rabbits with fibroma virus resulted in a decrease in infective virus titer between 0 and 48 h after infection (Table 4) . A similar reduction in virus titer was observed after infection of macrophages from adult tumor-bearing rabbits. Fibroma virus also failed to replicate in peritoneal macrophages taken from normal rabbits at 5, 7, and 14 days of age (Table 4) . These results were paralleled in macrophages taken from tumor-bearing rabbits inoculated with fibroma virus as newborns.
This experiment clearly demonstrated that there was no significant difference between adult and newborn rabbits in macrophage susceptibility to fibroma virus replication. DISCUSSION Tumors induced in newborn rabbits by fibroma virus increased in size for 3 to 4 weeks, reaching a maximum size of 5 to 7 cm in diameter. Whereas some animals died from the virus infection, others survived and showed a prolonged period of tumor regression lasting for 5 to 6 weeks. This was in contrast to tumors induced in adult rabbits which grew for 9 to 12 days and completely regressed by the end of the 3rd week. These results are consistent with observations of Allison (1) . Virus neutralization studies demonstrated that the antibody response did not differ appreciably in the adult and newborn tumor-bearing rabbits as shown by Allison (1) . Previous studies inl this laboratory also demonstrated significant titers of Table 1. b Macrophages were inoculated with 0.5 PFU of fibroma per cell at 4 C, washed, and growth was measured after 0 and 48 h of incubation at 37 C.
c Four rabbits.
cytotoxic antibodies in newborn tumor-bearing rabbits. We have no information at this time as to whether cell-cytotoxic and virus-neutralizing antibodies are the same or different.
Allison (1) reported that newbom rabbit skin tested between 1 and 3 weeks after tumor induction failed to elicit a delayed hypersensitivity reaction to fibroma antigens. Furthermore, he observed that lymph node lymphocytes from these animals were incapable of transferring a delayed hypersensitivity reaction when injected into the skin of adult tumor-bearing rabbits. He concluded from these experiments that cell-mediated immunity was defective in the newborn tumor-bearing rabbits.
Data presented in this paper also support the contention that cell-mediated immunity to fibroma tumors in newborn rabbits is markedly weaker than in adult rabbits. Repeated attempts to detect a delayed cutaneous hyperseInsitivity reaction to fibroma antigens in newborn rabbits with growing tumors failed. The delayed hypersensitivity reaction was readily demonstrable in adult tumor-bearing rabbits by the 1st week after 6,17 VO0L. 7, 1973 on October 14, 2017 by guest http://iai.asm.org/ Downloaded from TOMPKINS, SCHULTZ, AND ItAMA RAO tumor induction and at all times tested thereafter. This has to be interpreted with some caution, since, as stated by Allison (1) , it is technically difficult to introduce antigen into the thin skin of newborn rabbits anid be certain the antigein is retained at the site of inoculation. However, inoculation of live virus resulted in the formation of small intradermal tumor nodules at the site of inoculation after 2 to 4 days. Although these sites failed to show any evidence of a delayed cutaneous hypersensitivity reaction, the tumor nodules disappeared after several days, indicating immunity to re-infection. This observation is coInsistent with those of Allison (1, 2) , who suggested that antibody is the major mechanism of resistance to re-infection or prevention of spread of virus from the primary tumor.
The status of cell-mediated immunity to fibroma antigens in newborn rabbits was investigated further by employing the macrophage migration inhibition test. The lymphocytes from newborn tumor-bearing rabbits tested between 1 and 4 weeks after virus inoculation demonstrated only slight or no specific reactivity to fibroma antigens in the migration inhibition test. Whereas lymph node and peritoneal lymphocytes from these animals demonstrated a low level of immunity, lymphocytes from the spleen and thymus were consistently negative. In contrast, peritoneal exudates and lymph node lymphocytes from adult tumor-bearing rabbits showed a strong reaction to fibroma antigens in the migration inhibition test.
Whereas oinly weak specific lymphocyte reaction to fibroma antigens was detected in newborn tumor-bearing rabbits during the first 3 to 4 weeks of tumor growth, those rabbits surviving for longer periods demonstrated strong cell-mediated immunity to fibroma antigens by both the delayed cutaneous hypersensitivity reaction and the macrophage migration inhibitioin test. These data are in general agreement with previous investigations (1, 2) , and clearly show that the major difference in immune response to fibroma tumors between adult and newborn rabbits lies with the cell-mediated immune response and not humoral antibody.
Allison (1) Finally, macrophages accumulate at the site of a delayed hypersensitivity lesion and play a prominent role in resolution of the lesion. Likewise, large numbers of macrophages accumulate in and around the fibroma tumor in adult rabbits (1, 2) . Inoculation of cultured peritoneal macrophages from the control or tumor-bearing adult rabbits with fibroma virus resulted in abortive infections and a decrease in infective virus titers. Macrophages accumulating around the periphery of the tumor may play an important part in preventing the development of fibromas in adult animals by preventing virus spread to surrounding normal tissues. Whether or not these macrophages, in addition to preventing the spread of virus, might also function as aggressor cells against fibroma tumor cells and initiate regression of the existing tumor is not known.
In the case of newborn rabbits, there is some evidence to suggest that the macrophage or reticuloendothelial system is immature. It has been suggested that the generalized fibromatosis sometimes seen in newborn rabbits injected with fibroma virus might be due to the relative immaturity of the reticuloendothelial barriers to the spread of virus (1, 3) . In the case of fibroma virus, failure of the macrophage barrier to virus spread would Inot reflect an age-dependent resistance as has been reported for mouse macrophages to herpesvirus (4, 11), since macrophages from newborn and adult animals were equally effective in aborting virus replication. However, there does appear to be a quantitative difference in the macrophage population of adult and newborn rabbits. Allison showed that, whereas a dense ring of mononuclear cells surrounded the tumor in adult rabbits by the 9th day of growth, there was little mononuclear reaction around growing tumors in newborn rabbits (1) . Similarly, we observed large numbers of macrophages in primary cultures of tumors from adult rabbits, whereas very few macrophages were observed in cultures of tumors from newborn rabbits. Furthermore, repeated attempts to induce peritoneal exudates in newborn rabbits failed, suggesting a reduced reticuloendothelial activity. As the animals increased in age, there was a gradual increase in the number of macrophages that could be drawn into the peritoneal cavity. Warwick et al. (10) presented data to show that newboril rabbits are limited in their capacity to express or accept cell-transferred delayed hypersensitivity. These authors demoinstrated that the acceptance rate for passive transfer rose from 0% in the first week of life to 100% by the 4th week. One possible explanation for failure to passively transfer delayed hypersensitivity in newborns would be due to an immature reticuloendothelial system resulting in reduction in the number of macrophages available for recruitment into the anitigen inoculation site.
A similar explanation would explain the consistent failure to demonstrate a delayed hypersensitivity reaction in newborn rabbits with progressively growing tumors.
From this evidence, it is interestinig to speculate that failure of newborn rabbits to reject fibromas may depend not only on a depressed lymphocyte activity but also on a poorly developed macrophage system.
We have no information at this time as to whether lymphocytes or macrophages, or both, may function as aggressor cells in a cytotoxic reaction against the fibroma tumors. We presented evidence earlier that failure of cytotoxic antibody against tumor cells may be due to a loss or reduction in virus-induced surface antigens in the tumor cells (7) . Cell-mediated immunity, by the same reasoning, may prove ineffectual in these rabbits. Before any conclusions can be drawn relating progressive tumor growth in newborns to a depressed cell-mediated immunity, a clear demonstrat.ion of the cytotoxic potential of lymphocytes or macrophages, or both, from rabbits with regressing tumors must be accomplished.
